Home › Primitive Neuroectodermal Tumors › Alabama
Primitive Neuroectodermal Tumors clinical trials in Alabama
3 studies for Primitive Neuroectodermal Tumors are looking for participants at sites in Alabama.
Cities in Alabama
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Alabama/Children's of Alabama, Birmingham
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Embryonal Tumor With Multilayered Rosettes
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
All ages · All sexes · Updated Jun 29, 2026 · NCT06861244From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.